Mettler-Toledo International (NYSE:MTD) Price Target Cut to $670.00

Mettler-Toledo International (NYSE:MTD) had its price objective decreased by investment analysts at UBS Group from $680.00 to $670.00 in a note issued to investors on Friday, AnalystRatings.com reports. The brokerage presently has a “sell” rating on the medical instruments supplier’s stock. UBS Group’s price objective would suggest a potential downside of 5.48% from the stock’s previous close.

Several other research firms have also issued reports on MTD. Barclays dropped their price objective on shares of Mettler-Toledo International from $680.00 to $640.00 and set an “underweight” rating for the company in a research report on Wednesday, October 9th. ValuEngine lowered shares of Mettler-Toledo International from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Zacks Investment Research lowered shares of Mettler-Toledo International from a “hold” rating to a “sell” rating and set a $760.00 price objective for the company. in a research report on Tuesday, November 5th. Finally, Bank of America dropped their price objective on shares of Mettler-Toledo International from $830.00 to $720.00 and set a “neutral” rating for the company in a research report on Thursday, October 17th. Five investment analysts have rated the stock with a sell rating and one has assigned a hold rating to the company’s stock. Mettler-Toledo International currently has a consensus rating of “Sell” and an average target price of $697.50.

NYSE:MTD traded down $11.95 during trading hours on Friday, reaching $708.86. 410,664 shares of the company were exchanged, compared to its average volume of 167,265. Mettler-Toledo International has a 52-week low of $500.74 and a 52-week high of $873.51. The stock has a 50 day simple moving average of $694.04 and a 200 day simple moving average of $734.92. The firm has a market cap of $17.58 billion, a price-to-earnings ratio of 34.88, a PEG ratio of 2.33 and a beta of 1.37. The company has a debt-to-equity ratio of 2.16, a current ratio of 1.39 and a quick ratio of 0.98.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $5.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.71 by $0.06. Mettler-Toledo International had a net margin of 18.45% and a return on equity of 98.65%. The company had revenue of $753.90 million during the quarter, compared to analyst estimates of $751.34 million. During the same quarter in the prior year, the business earned $5.12 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, analysts predict that Mettler-Toledo International will post 22.7 EPS for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in MTD. SG Americas Securities LLC grew its holdings in Mettler-Toledo International by 920.0% during the 2nd quarter. SG Americas Securities LLC now owns 2,244 shares of the medical instruments supplier’s stock valued at $1,885,000 after purchasing an additional 2,024 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in Mettler-Toledo International by 7.8% during the 2nd quarter. Asset Management One Co. Ltd. now owns 20,953 shares of the medical instruments supplier’s stock valued at $17,599,000 after purchasing an additional 1,523 shares in the last quarter. Rhumbline Advisers grew its holdings in Mettler-Toledo International by 4.3% during the 3rd quarter. Rhumbline Advisers now owns 68,489 shares of the medical instruments supplier’s stock valued at $48,244,000 after purchasing an additional 2,818 shares in the last quarter. Empowered Funds LLC acquired a new stake in Mettler-Toledo International during the 3rd quarter valued at $1,309,000. Finally, Achmea Investment Management B.V. grew its holdings in Mettler-Toledo International by 35.7% during the 2nd quarter. Achmea Investment Management B.V. now owns 1,847 shares of the medical instruments supplier’s stock valued at $1,553,000 after purchasing an additional 486 shares in the last quarter. 97.18% of the stock is owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Recommended Story: Why do analysts give a neutral rating?

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.